Search Results 891-900 of 16747 for CLL
-
Jacksonville, Fla. The purpose of this study is to explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as ...
-
c. Cancer Biology and Translational Research: John A. Copland III · Cancer Research and Cellular Therapies: Januario E. Castro · Cardiovascular Tissue ...
-
Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.
-
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Ibrutinib may stop the growth of tumor cells by ...
-
This randomized phase II trial studies how well transoral surgery followed by low-dose or standard-dose radiation therapy works in treating patients with human ...
-
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
-
Dr. Willman is an internationally renowned physician scientist and a pioneer in the field of cancer precision medicine with a track record of innovation and ...
-
Life expectancy less than 12 months, for example, chronic kidney disease ≥ stage IV, or cancer with poor prognosis (e.g., CLL, CML, etc.). Participating in ...
-
This will be assessed in patients with chronic spontaneous urticaria (CSU) who have completed a preceding ligelizumab study and have relapsed, following ...
-
Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...